AUCO.L vs. BIOT.L
AUCO.L (L&G Gold Mining UCITS ETF) and BIOT.L (L&G Pharma Breakthrough UCITS ETF - USD Accumulating ETF) are both exchange-traded funds - AUCO.L is a Gold fund tracking the STOXX Global Gold Miners Index, while BIOT.L is a Health & Biotech Equities fund tracking the Solactive Pharma Breakthrough Value Index Net Total Return. Both are passively managed. Over the past 5 years, AUCO.L returned 21.25%/yr vs 2.89%/yr for BIOT.L. At a 0.25 correlation, their price movements are largely independent. AUCO.L charges 0.55%/yr vs 0.49%/yr for BIOT.L.
Performance
AUCO.L vs. BIOT.L - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, AUCO.L achieves a -17.51% return, which is significantly lower than BIOT.L's 8.59% return.
AUCO.L
- 1D
- -1.23%
- 1M
- -20.57%
- 6M
- -25.53%
- YTD
- -17.51%
- 1Y
- 44.33%
- 3Y*
- 38.85%
- 5Y*
- 21.25%
- 10Y*
- 11.70%
BIOT.L
- 1D
- 0.07%
- 1M
- 6.33%
- 6M
- 9.47%
- YTD
- 8.59%
- 1Y
- 32.65%
- 3Y*
- 10.27%
- 5Y*
- 2.89%
- 10Y*
- —
AUCO.L vs. BIOT.L - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|
AUCO.L L&G Gold Mining UCITS ETF | -17.51% | 181.83% | 17.96% | 15.02% | -14.30% | -10.12% | 21.72% | 44.14% | -14.07% |
BIOT.L L&G Pharma Breakthrough UCITS ETF - USD Accumulating ETF | 8.59% | 36.47% | -5.31% | -9.28% | -8.41% | -3.60% | 28.29% | 13.02% | -8.12% |
Correlation
The correlation between AUCO.L and BIOT.L is 0.33, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.33 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.28 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.31 |
Correlation (All Time) Calculated using the full available price history since Jan 18, 2018 | 0.25 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
AUCO.L vs. BIOT.L — Risk / Return Rank
AUCO.L
BIOT.L
AUCO.L vs. BIOT.L - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for L&G Gold Mining UCITS ETF (AUCO.L) and L&G Pharma Breakthrough UCITS ETF - USD Accumulating ETF (BIOT.L). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| AUCO.L | BIOT.L | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.71 | ||
| Sortino ratioReturn per unit of downside risk | -0.90 | ||
| Omega ratioGain probability vs. loss probability | 1.17 | 1.27 | -0.10 |
| Calmar ratioReturn relative to maximum drawdown | 1.15 | 3.40 | -2.26 |
| Martin ratioReturn relative to average drawdown | 2.68 | 9.73 | -7.05 |
Loading charts...
Drawdowns
AUCO.L vs. BIOT.L - Drawdown Comparison
The maximum AUCO.L drawdown since its inception was -78.30%, which is greater than BIOT.L's maximum drawdown of -34.44%. Use the drawdown chart below to compare losses from any high point for AUCO.L and BIOT.L.
Loading charts...
Drawdown Indicators
| AUCO.L | BIOT.L | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -78.30% | -34.44% | -43.86% |
Max Drawdown (1Y)Largest decline over 1 year | -38.48% | -9.55% | -28.93% |
Max Drawdown (3Y)Largest decline over 3 years | -38.48% | -19.91% | -18.57% |
Max Drawdown (5Y)Largest decline over 5 years | -48.62% | -33.80% | -14.82% |
Max Drawdown (10Y)Largest decline over 10 years | -54.47% | — | — |
Current DrawdownCurrent decline from peak | -38.48% | -5.43% | -33.05% |
Average DrawdownAverage peak-to-trough decline | -40.73% | -13.31% | -27.42% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 16.47% | 3.35% | +13.12% |
Volatility
AUCO.L vs. BIOT.L - Volatility Comparison
L&G Gold Mining UCITS ETF (AUCO.L) has a higher volatility of 13.97% compared to L&G Pharma Breakthrough UCITS ETF - USD Accumulating ETF (BIOT.L) at 5.96%. This indicates that AUCO.L's price experiences larger fluctuations and is considered to be riskier than BIOT.L based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| AUCO.L | BIOT.L | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 13.97% | 5.96% | +8.01% |
Volatility (6M)Calculated over the trailing 6-month period | 39.44% | 15.54% | +23.90% |
Volatility (1Y)Calculated over the trailing 1-year period | 48.93% | 20.19% | +28.74% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 38.98% | 18.62% | +20.36% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 35.75% | 19.50% | +16.25% |
AUCO.L vs. BIOT.L - Expense Ratio Comparison
AUCO.L has a 0.55% expense ratio, which is higher than BIOT.L's 0.49% expense ratio.
Dividends
AUCO.L vs. BIOT.L - Dividend Comparison
Neither AUCO.L nor BIOT.L has paid dividends to shareholders.
Frequently Asked Questions
AUCO.L and BIOT.L have a correlation of 0.33, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, BIOT.L is cheaper at 0.49% per year. The better choice depends on whether you care most about return, fees, risk, or income.
BIOT.L is cheaper with a 0.49% expense ratio, compared with 0.55% for AUCO.L.
AUCO.L is categorized as Gold, while BIOT.L is Health & Biotech Equities. AUCO.L tracks STOXX Global Gold Miners Index, while BIOT.L tracks Solactive Pharma Breakthrough Value Index Net Total Return. Their fees differ too: 0.55% for AUCO.L and 0.49% for BIOT.L.
Find the right allocation for AUCO.L and BIOT.L
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer